Investment Fraud Lawyers

Investment Fraud Lawyers is led by founding partners Jason S. Haselkorn (FL Bar No. 52140) and Matthew R. Thibaut (FL Bar No. 514918) of Haselkorn & Thibaut, P.A. Former Wall Street defense attorneys and previously licensed securities brokers, they now represent individual investors nationwide in FINRA arbitration and securities litigation. The firm focuses on investment fraud and securities cases involving broker misconduct, unsuitable recommendations, and fraudulent schemes, with an approximately 98% success rate across hundreds of matters and more than 95 years of combined securities law experience. From offices in Florida, New York, Arizona, Texas, and North Carolina, the firm typically handles investor cases on a contingency‑fee basis — there is no attorney’s fee unless a financial recovery is obtained.

Financial Advisor Lost My Money

Kestra Investment Services Advisor Matthew Carbray Faces Investor Scrutiny

Haselkorn & Thibaut has initiated an investigation into Matthew Carbray, a financial advisor based in Avon, Connecticut, affiliated with Kestra Investment Services and Kestra Advisory Services (d/b/a Ridgeline Financial Partners). Investors who have concerns about their investments with Mr. Carbray are encouraged to reach out for a free consultation to discuss their options and next […]

Kestra Investment Services Advisor Matthew Carbray Faces Investor Scrutiny Read More »

Financial Advisor Lost My Money

Investigation Targets Ken Arena at Cetera Wealth Services, Formerly of Newbridge Securities

Ken Arena, Pompano Beach, Florida – Cetera Wealth Services & Newbridge Securities Corporation: Comprehensive Advisor Review and Investor Alert Haselkorn & Thibaut, a national investment fraud law firm with over 95 years of combined experience, a 98% success rate, and millions recovered for clients, has opened an investigation regarding financial advisor Ken Arena (CRD# 6997),

Investigation Targets Ken Arena at Cetera Wealth Services, Formerly of Newbridge Securities Read More »

Featured image: Non-Traded REIT Valuations 2026

Non-Traded REIT Valuations 2026: Which Products Are Frozen?

Non-Traded REIT Valuations 2026: Which Products Are Frozen? Table of Contents Toggle Non-Traded REIT Valuations 2026: Which Products Are Frozen? The Non-Traded REIT Valuation Crisis: Where Things Stand Current Status of Major Non-Traded REIT Products NorthStar Healthcare REIT Griffin-American Healthcare REIT IV (Now Peakstone REIT) Carter Validus Mission Critical REIT InvenTrust (Formerly Inland American Real

Non-Traded REIT Valuations 2026: Which Products Are Frozen? Read More »

Scroll to Top